Search Criteria: Research Area is "Reproductive Biology Research: Prostate Tumors"
| Stock Number |
Strain Name Phenotype |
Standard Supply |
| 008215 | (C57BL/6-Tg(TRAMP)8247Ng/J X FVB/NJ)F1/J | Repository- Live |
| Mice carrying the TRAMP (Transgenic Adenocarcinoma of Mouse Prostate) transgene develop progressive forms of prostate cancer with distant site metastasis, primarily to the lymph nodes and lungs. These transgenic mice express the simian virus 40 (SV40) large tumor T antigen (Tag) under the control of the rat probasin promoter. Expression of the transgene is specific to the prostate epithelium. Transgenic mice exhibit various forms of disease from mild intraepithelial hyperplasia to large multinodular malignant neoplasia. The median survival time for these F1 transgenic mice is 19 weeks, very few mice survive past 33 weeks of age, which is significantly shorter than the lifespan of transgenic mice on the C57BL/6 background. Comparative histological analysis of tumors from these F1 transgenic mice and from transgenic mice on the C57BL/6 background reveals that the tumors found in these F1 mutants arise from the dorsolateral and ventral lobes of the prostate and are more spherical, hig
..... For more information please see the full phenotype on the strain data sheet | ||
| 003135 | C57BL/6-Tg(TRAMP)8247Ng/J | Repository- Live |
| Mice carrying the (TRAMP) transgene develop progressive forms of prostate cancer with distant site metastasis. Transgenic mice exhibit various forms of disease from mild intraepithelial hyperplasia to large multinodular malignant neoplasia. Tumors have been detected in the prostate as early as 10 weeks of age. The tumors have elevated levels of nuclear TRP53 and decreased androgen receptor expression. | ||
| 003382 | B10.D2-Tg(C3-1-TAg)cJeg/J | Repository-Cryopreserved |
| This transgenic strain is a model for the study of multistage oncogenesis in the prostate and mammary glands. Male transgenic mice develop prostatic hyperplasia in early life that progresses to adenoma or adenocarcinoma in about half of the animals which survive longer 7 months of age. Female animals generally develop mammary intraepithelial neoplasia with similarities to DCIS by 3 months of age with subsequent development of mammary adenocarcinoma by 6 months of age in 100% of the animals. About 10 - 15% of female mice develop lung metastases, although lung metastases from prostate cancer is extremely rare. Bone metastases have not been observed. Please note that the phenotype description above was developed for this allele on an FVB background (stock number 3381). The mammary and prostate tumor phenotypes may be different on the C57BL/10 background in this strain. | ||
| 003380 | B6.FVB-Tg(C3-1-TAg)cJeg/J | Repository-Cryopreserved |
| TgN(C3-1-TAg)cJeg mice are transgenic for the SV-40 Large tumor antigen (TAg) driven by the rat prostatic steroid binding protein (C3(1))promoter. Male mice survive up to 11 months of age. They develop hyperplastic changes in the prostate epithelium which progress to prostate adenocarcinoma in the majority of mice after 8 months of age. Carcinogenic changes in female mice begin with development of hyperplasia of the mammary gland ducts and acini by 3 months of age and progress to multifocal mammary adenocarcinoma with death by 6 month of age. Homozygous mothers can bear offspring but pregnancy appears to accelerate tumor development and foster mothers are required for pups due to lactation difficulties. Evidence of pulmonary metastases has been seen in both male and female mice. These C3-1-TAg transgenic mice provide a model to study TAg-induced progression of hormone responsive tumors. Please note that the phenotype description above was developed for this allele on an FVB backgrou
..... For more information please see the full phenotype on the strain data sheet | ||
| 003381 | FVB-Tg(C3-1-TAg)cJeg/J | Repository-Cryopreserved |
| This transgenic strain is a model for the study of multistage oncogenesis in the prostate and mammary glands. Male transgenic mice develop prostatic hyperplasia in early life that progresses to adenoma or adenocarcinoma in about half of the animals which survive longer 7 months of age. Female animals generally develop mammary intraepithelial neoplasia with similarities to DCIS by 3 months of age with subsequent development of mammary adenocarcinoma by 6 months of age in 100% of the animals. About 10 - 15% of female mice develop lung metastases, although lung metastases from prostate cancer is extremely rare. Bone metastases have not been observed. The phenotype for this transgene has been most extensively studied in the FVB/N background. | ||
(5 stocks) Back to Top
Send questions to our Technical Support team using the Express Technical Support Form.
(2.15)